Testing rapamycin effect on exercise muscle function in older adults
Part of Brain & nervous system clinical trials.
This study looks at how rapamycin (a medication that affects a growth signal in the body) changes muscle responses when older adults do resistance exercise. It may help researchers understand whether this treatment could improve or alter muscle function with aging.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can understand the study and sign informed consent
- You are physically able to safely complete a resistance exercise training program
- Your body mass index (BMI) is between 18 and 35
- You do not have serious active heart, lung, or stroke-related conditions that are not well controlled
- You do not have major metabolic, clotting, or significant nerve or muscle problems (example given: epilepsy)
- You can safely have MRI scans and you can take rapamycin without vaccine timing conflicts
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two FDA-approved drugs, rapamycin and everolimus, to see if they can improve immune function in healthy older adults. You may join if you are generally healthy, live independently, and are between 65 and 90 years old.
This trial tests whether combining resistance training with the drug rapamycin can improve bone formation in postmenopausal women who have lower-than-normal bone density but not osteoporosis. It aims to find a new way to strengthen bones and prevent fractures.
This trial tests an investigational drug called AMC6156 to see if it can help improve muscle mass and strength in older adults with sarcopenia (age-related muscle loss). Participants will also follow exercise and nutrition guidance.
This early-phase study tests how a medicine called rapalog affects the body in generally healthy middle-aged adults. It may help researchers understand safety and dosing, but it’s not meant to treat an existing disease.
This trial tests whether a type of strength training, called pre-conditioning functional resistance training, can help older adults who are already experiencing low muscle strength. The goal is to see if this exercise approach is safe and practical before starting a larger study.
This study looks at whether a body pathway called mTOR helps control how your body handles insulin and blood sugar. It’s done in healthy men to understand insulin sensitivity before testing approaches in people with health problems later.
Hear when a new Muscle Atrophy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.